Skip to main content
Top

Medical Oncology

Issue 7/2016

Content (23 Articles)

Original Paper

A look inside the mechanistic black box: Are red blood cells the critical effectors of RRx-001 cytotoxicity?

Pedro Cabrales, Jan Scicinski, Tony Reid, Frans Kuypers, Sandra Larkin, Marcel Fens, Arnold Oronsky, Bryan Oronsky

Original Paper

Letrozole-induced functional changes in carcinoma-associated fibroblasts and their influence on breast cancer cell biology

Kaifu Li, Hua Kang, Yajun Wang, Tao Hai, Guohua Rong, Haichen Sun

Original Paper

Malignant gliomas induce and exploit astrocytic mesenchymal-like transition by activating canonical Wnt/β-catenin signaling

Ping Lu, Yajing Wang, Xiuting Liu, Hong Wang, Xin Zhang, Kequan Wang, Qing Wang, Rong Hu

Original Paper

ABO blood groups in relation to breast carcinoma incidence and associated prognostic factors in Moroccan women

S. Zouine, F. Marnissi, N. Otmani, M. Bennani Othmani, M. El Wafi, K. Kojok, Y. Zaid, N. Tahiri Jouti, N. Habti

Original Paper

Limited significance of curative surgery in Borrmann type IV gastric cancer

Eun Young Kim, Han Mo Yoo, Kyo Young Song, Cho Hyun Park

Original Paper

Neuropeptide Y1 receptor inhibits cell growth through inactivating mitogen-activated protein kinase signal pathway in human hepatocellular carcinoma

Xiufang Lv, Fengbo Zhao, Xisong Huo, Weidong Tang, Baoying Hu, Xiu Gong, Juan Yang, Qiujin Shen, Wenxin Qin

Original Paper

Comparison of KRAS mutation status between primary tumor and metastasis in Chinese colorectal cancer patients

Zhe-Zhen Li, Long Bai, Feng Wang, Zi-Chen Zhang, Fang Wang, Zhao-Lei Zeng, Jun-Bo Zeng, Dong-Sheng Zhang, Feng-Hua Wang, Zhi-Qiang Wang, Yu-Hong Li, Jian-Yong Shao, Rui-Hua Xu

Original Paper

Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT/Cyclin D1/CDK4 pathway in vitro and in vivo

Meng Gao, Yanyan Ma, Robert C. Bast Jr., Yue Li, Lu Wan, Yanping Liu, Yingshuo Sun, Zhenghui Fang, Lining Zhang, Xiaoyan Wang, Zengtao Wei

Original Paper

Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients

Pierfrancesco Franco, Francesca Arcadipane, Riccardo Ragona, Adriana Lesca, Elena Gallio, Massimiliano Mistrangelo, Paola Cassoni, Vincenzo Arena, Sara Bustreo, Riccardo Faletti, Nadia Rondi, Mario Morino, Umberto Ricardi

Original Paper

Expression level and methylation status of three tumor suppressor genes, DLEC1, ITGA9 and MLH1, in non-small cell lung cancer

Dorota Pastuszak-Lewandoska, Jacek Kordiak, Adam Antczak, Monika Migdalska-Sęk, Karolina H. Czarnecka, Paweł Górski, Ewa Nawrot, Justyna M. Kiszałkiewicz, Daria Domańska-Senderowska, Ewa Brzeziańska-Lasota

Original Paper

Non-surgical organ preservation strategies for locally advanced laryngeal tumors: what is the Italian attitude? Results of a national survey on behalf of AIRO and AIOM

D. Alterio, P. Franco, G. Numico, L. Licitra, M. Cossu Rocca, A. Ferrari, C. Pinto, E. G. Russi, U. Ricardi, B. A. Jereczek Fossa

Original Paper

Docetaxel-related toxicity in metastatic hormone-sensitive and metastatic castration-resistant prostate cancer

Michael T. Schweizer, Roman Gulati, Elahe A. Mostaghel, Peter S. Nelson, R. Bruce Montgomery, Evan Y. Yu, Heather H. Cheng

Original Paper

Use of complementary and alternative medicine by patients with cancer: a cross-sectional study at different points of cancer care

J. Kleine Wortmann, A. Bremer, HT Eich, HP Kleine Wortmann, A. Schuster, J. Fühner, J. Büntzel, R. Muecke, FJ Prott, J. Huebner

Original Paper

Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC)

M. Abbas, S. Steffens, M. Bellut, H. Eggers, A. Großhennig, J. U. Becker, G. Wegener, A. J. Schrader, V. Grünwald, P. Ivanyi

Original Paper

Medical hospitalizations in prostate cancer survivors

Jerome Gnanaraj, Shobana Balakrishnan, Zarish Umar, Emmanuel S. Antonarakis, Christian P. Pavlovich, Scott M. Wright, Waseem Khaliq

Review Article

The role of IL-37 in cancer

Vivi A. Ding, Ziwen Zhu, Huaping Xiao, Mark R. Wakefield, Qian Bai, Yujiang Fang

Short Communication

A pilot trial of FLOT neoadjuvant chemotherapy for resectable esophagogastric junction adenocarcinoma

Ali Al-Fakeeh, Lorenzo Ferri, Nasser Mulla, Tonia Doerksen, Ibrahim Al-Ruzug, Fabiano Santos, Thierry Alcindor

Short Communication

Sequential addition of aprepitant in patients receiving carboplatin-based chemotherapy

Seiichiro Suzuki, Masato Karayama, Naoki Inui, Shigeki Kuroishi, Tomoyuki Fujisawa, Noriyuki Enomoto, Yutaro Nakamura, Koshi Yokomura, Mikio Toyoshima, Shiro Imokawa, Kazuhiro Asada, Masafumi Masuda, Takashi Yamada, Hiroshi Watanabe, Hiroshi Hayakawa, Takafumi Suda

Short Communication

Anthracycline- and trastuzumab-induced cardiotoxicity: a retrospective study

Yasmin Hamirani, Ibrahim Fanous, Christopher M. Kramer, Andrew Wong, Michael Salerno, Patrick Dillon